May 12, 2025:

The Big Ten Cancer Research Consortium (Big Ten CRC) is set to participate in the American Society of Clinical Oncology® (ASCO) 2025 Annual Meeting in Chicago from May 30 to June 3. During the event, two Big Ten CRC studies will be presented, working group meetings will take place, and the Big Ten CRC will host a joint reception with Hoosier Cancer Research Network (HCRN). The Big Ten CRC will also be represented in the exhibit hall at HCRN’s booth, #37116.

Study Presentations

Two Big Ten CRC studies, BTCRC-GI22-588 and BTCRC-LUN16-081, will be presented during ASCO.

BTCRC-GI22-588: A phase II study of pembrolizumab, carboplatin, paclitaxel, and radiation for the treatment of early-stage anal cancer

• Authors: Anita Turk, Salma Jabbour, Yixing Jiang, Dustin Deming
• Poster Session: Gastrointestinal Cancer – Colorectal and Anal
• Poster Bd #: 302a
• Abstract: https://meetings.asco.org/abstracts-presentations/252311

BTCRC-LUN16-081: Evaluating inflammatory biomarkers as predictors of outcomes and immune-related adverse events (irAE) in the Big Ten Cancer Research Consortium (BTCRC) LUN16-081 phase II clinical trial

• Authors: Greg Durm, Sandra Althouse, Hirva Mamdani, Tushar Sardesai, Shadia Jalal, Nasser Hanna
• Publication-Only: Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
• Abstract: https://meetings.asco.org/abstracts-presentations/250259

Working Group Meetings

The Big Ten CRC will post in-person meeting for the Gastrointestinal, Genitourinary, and Thoracic Clinical Trial Working Groups during ASCO 2025. For more information or to schedule time to meet with HCRN, please reach out to Jonathan Ang at jang@hoosiercancer.org.

Reception

Hoosier Cancer Research Network (HCRN) is hosting a combined reception for members of both HCRN and the Big Ten Cancer Research Consortium on Saturday, June 1 from 6:30 – 8:00 pm CT. This gathering will take place at voco Chicago Downtown 350 W. Wolf Point Plaza, in the LaSalle Room. For more information, please contact Suzanne Tansel at stansel@hoosiercancer.org.

About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow. Since its founding, the Big Ten CRC has activated nearly 40 clinical trials across a wide range of cancer types, more than 1,000 participants have enrolled in Big Ten CRC studies, and more than 500 researchers have joined Big Ten CRC Clinical Trial Working Groups.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 18 Big Ten institutions provide direct financial support for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women. For more information, visit www.bigten.org.